Levobunolol hydrochloride is a hydrochloride obtained by combining equimolar amounts of levobunolol and hydrochloric acid. A non-selective beta-adrenergic antagonist used for treatment of glaucoma. Among its listed roles, it functions as a beta-adrenergic antagonist and an antiglaucoma drug. It includes a levobunolol(1+). It is grouped under the following drug class(es): Beta blockers and Ophthalmic beta-blockers. Its therapeutic use is listed as ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Akbeta, Betagan and Gotensin. Its PubChem CID is 5284409.
Levobunolol hydrochloride
| CAS No | 27912-14-7 |
|---|---|
| Molecular Formula | C17H26ClNO3 |
| Molecular Weight | 327.80 g/mol |
| Synonyms | 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Levobunolol hydrochloride is a hydrochloride obtained by combining equimolar amounts of levobunolol and hydrochloric acid. A non-selective beta-adrenergic antagonist used for treatment of glaucoma.
The listed CAS number is 27912-14-7.
The listed molecular formula is C17H26ClNO3.
The listed molecular weight is 327.80 g/mol.
5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride.
The source lists Akbeta, Betagan and Gotensin.